DaVita Kidney Care, a provider of kidney care services, has acquired three haemodialysis centres from Malaysian dialysis provider Sinar Indentiti to further expand its care of kidney patients in the country.
With the addition of Sinar Indentiti’s three new centres, DaVita now operates a total of 24 centres in both peninsular and east Malaysia.
In Malaysia, kidney disease is a growing health concern. According to the Malaysian Society of Nephrology, over 30,000 patients receive life-sustaining dialysis treatments, a population that has grown nearly 12% year over year.
DaVita Kidney Care Asia-Pacific region president Atul Mathur said that DaVita is committed to raising the standard of care for chronic kidney disease patients in Malaysia.
"As we continue to seek opportunities to bring DaVita’s industry-leading outcomes to chronic kidney disease populations in the country, we believe Malaysia’s kidney patients ultimately benefit," Mathur added.
Sinar Indentiti nephrologist and clinic medical director with DaVita Dr Gan Wee Hin said that South-East Asia’s growing population is resulting in an increase of patients suffering from chronic kidney disease.
"I strongly believe by joining DaVita – an organisation that has vast experience and an impressive record all over the world – we can improve clinical outcomes in our group of patients," Dr Hin added.
DaVita has witnessed an improvement in clinical outcomes each year since 2000 in the US and has consistently established clinical results that are among the best in virtually every category in the kidney care industry.
These outcomes help drive lower mortality rates and fewer hospitalisations, directly supporting DaVita’s aim to improve patients’ health and quality of life.
DaVita Kidney Care is a division of DaVita HealthCare Partners (DVA). As of 31 December 2013, DaVita Kidney Care operated or provided administrative services at 2,074 outpatient dialysis centres in the US, serving approximately 163,000 patients.
The company also operated 73 outpatient dialysis centres located in ten countries outside the US.